Table 1.

Characteristics of patients in TCGA and ICGC datasets.

Variable	TCGA (N = 485)	ICGC (N = 144)
Age (years)
≤60	219 (45%)	59 (41%)
>60	266 (55%)	85 (59%)
Race
Asian	12 (2%)	Not applicable
Black or African American	56 (12%)	Not applicable
White	404 (83%)	Not applicable
Others	13 (3%)	Not applicable
Gleason score
6	46 (9%)	29 (20%)
7	245 (51%)	80 (56%)
8	59 (12%)	9 (6%)
9	131 (27%)	2 (1%)
10	4 (1%)	Not applicable
Other	0 (0%)	24 (17%)
Prostate-specific antigen (ng/ml)
<4	402 (83%)	Not applicable
≥4	26 (5%)	Not applicable
No detection	57 (12%)	Not applicable
T stage
T1	0 (0%)	83 (58%)
T2	188 (39%)	61 (42%)
T3	280 (58%)	0 (0%)
T4	10 (2%)	0 (0%)
No detection	7 (1%)	0 (0%)
N stage
N0	442 (91%)	Not applicable
N1	3 (1%)	Not applicable
No detection	40 (8%)	Not applicable
M stage
M0	336 (69%)	Not applicable
M1	77 (16%)	Not applicable
No detection	72 (15%)	Not applicable
Tumor status
Tumor free	338 (70%)	Not applicable
With tumor	88 (18%)	Not applicable
No detection	59 (12%)	Not applicable
New event
No	357 (74%)	Not applicable
Yes	104 (21%)	Not applicable
No detection	24 (5%)	Not applicable
Radiation therapy
No	383 (79%)	Not applicable
Yes	59 (12%)	Not applicable
No detection	43 (9%)	Not applicable
Primary therapy outcome
Complete response	331 (68%)	Not applicable
Progressive disease	26 (5%)	Not applicable
Partial response	40 (8%)	Not applicable
Stable disease	29 (6%)	Not applicable
Other	59 (12%)	Not applicable
Residual tumor
R0	206 (42%)	Not applicable
R1	144 (30%)	Not applicable
R2	5 (1%)	Not applicable
No detection	130 (27%)	Not applicable
Zone of origin
Central zone	4 (1%)	Not applicable
Overlapping/multiple zones	124 (26%)	Not applicable
Peripheral zone	134 (28%)	Not applicable
Transition zone	7 (1%)	Not applicable
No detection	216 (45%)	Not applicable

Data were shown as n (%).